secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001801170-22-000090
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health appoints Dr. Anna Loengard to Board of Directors
--------------------------------------------------------------

- Anna Loengard, M.D. appointed as Class I director effective November 28, 2022.
- She will receive a pro-rata annual retainer and a pro-rated RSU award valued at $200,000.
- Previously served as CMO of AccentCare, Caravan Health, and Queen's Healthcare System.
- Her geriatric medicine and value-based care expertise supports Clover's in-home primary care strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/0001801170-22-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/clov-20221128.htm
  HTML page:      https://secwatch.observer/filing/0001801170-22-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer